Heterozygous, rare, predicted loss-of-function variants in APOB have been described in other patients with cryptogenic cirrhosis and suggested to contribute to severe disease, including predisposition to hepatocellular carcinoma development.[17], [18], [19], [20], [21]. This evidence concerns the gene APOB and hepatocellular carcinoma.